Article Text

other Versions

The influence of discrepant imaging judgements on the classification of axial spondyloarthritis is limited: a replication in the SpondyloArthritis Caught Early (SPACE) cohort
  1. Zineb Ez-Zaitouni1⇑,
  2. Miranda van Lunteren1,
  3. Pauline A C Bakker1,
  4. Rosaline van den Berg1,
  5. Monique Reijnierse2,
  6. Karen Minde Fagerli3,
  7. Robert B M Landewé4,
  8. Roberta Ramonda5,
  9. Lennart T H Jacobsson6,
  10. Floris A van Gaalen1,
  11. Désirée van der Heijde1
  1. 1 Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  2. 2 Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
  3. 3 Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
  4. 4 Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands
  5. 5 Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua, Italy
  6. 6 Department of Rheumatology, University of Göteborg, Göteborg, Sweden
  1. Correspondence to Zineb Ez-Zaitouni, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands; z.ez-zaitouni{at}

Statistics from

Sacroiliitis on imaging is important in the diagnosis and classification of patients with axial spondyloarthritis (axSpA). In the Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axSpA, sacroiliitis is defined as either radiographic sacroiliitis (X-SI) according to the modified New York (mNY) criteria or active inflammation on MRI sacroiliac joints (MRI-SI) highly suggestive of axSpA (ASAS definition).1–4 According to the ASAS criteria, patients with chronic back pain are classified via the imaging arm when sacroiliitis on MRI-SI or X-SI plus ≥1 spondyloarthritis (SpA) feature is present, or via the clinical arm where ≥2 SpA features in addition to Human Leukocyte Antigen B27 (HLA-B27) have to be present.

While local clinicians can interpret imaging of the sacroiliac joints in the context of clinical information, central readers of research studies …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.